BRCA mutation status is not associated with increased hematologic toxicity among patients undergoing platinum-based chemotherapy for ovarian cancer
International Journal of Gynecological Cancer | Feb 02, 2018
International Journal of Gynecological Cancer | Feb 02, 2018